Peptide Stacking: How Physicians Combine Peptides for Maximum Results
Peptide stacking combines two or more peptides targeting different receptors or biological pathways to achieve synergistic rather than merely additive effects. Physician-designed…
Tesamorelin: The FDA-Approved Growth Hormone Peptide for Body Composition
Tesamorelin is a synthetic GHRH analogue and the only peptide FDA-approved specifically for visceral fat reduction (Egrifta, for HIV-associated lipodystrophy). The LONO…
AOD-9604: The Fat-Loss Peptide Fragment With a Precision Mechanism
AOD-9604 is a synthetic fragment of human growth hormone (amino acids 176-191) engineered to isolate the lipolytic domain while eliminating IGF-1 stimulation…
MOTS-c: The Exercise Mimetic Peptide That Resets Metabolic Health
MOTS-c is a mitochondrial-derived peptide encoded in the 12S rRNA region of mtDNA that activates AMPK, drives glucose uptake independent of insulin,…
SS-31 (Elamipretide): The Mitochondrial Peptide That Restores Cellular Energy
SS-31 is a synthetic tetrapeptide that selectively concentrates in the inner mitochondrial membrane and binds cardiolipin — the structural lipid that determines…
Thymosin Alpha-1 (TA-1): The Immune System Peptide That Resets Your Defense Network
Thymosin Alpha-1 is a 28-amino acid peptide that activates dendritic cells, upregulates NK cells, and modulates T-cell responses — producing bidirectional immune…
What Is Peptide Therapy? The Complete Patient Guide
Peptide therapy uses short-chain amino acid sequences to deliver precise, targeted signals to specific cell receptors — triggering natural processes like growth…
Semax: The Focus Peptide
Semax is a synthetic ACTH(4-10) analogue developed in Russia that increases BDNF by up to 800%, enhances dopamine and serotonin signaling, and…
Selank: Calm Without the Fog
Selank is a synthetic heptapeptide that modulates GABA, increases BDNF, and reduces cortisol — producing clinical anxiety relief comparable to benzodiazepines without…
When to Upgrade Your GLP-1
Retatrutide is a triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously — producing 24% body weight loss in Phase 2 trials…